The 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mouse Model
- 1 June 2003
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 991 (1) , 189-198
- https://doi.org/10.1111/j.1749-6632.2003.tb07476.x
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Engineered modeling and the secrets of Parkinson's diseaseTrends in Neurosciences, 2001
- Oxidative post‐translational modifications of α‐synuclein in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) mouse model of Parkinson's diseaseJournal of Neurochemistry, 2001
- Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonismJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Threshold Effects and Control of Oxidative Phosphorylation in Nonsynaptic Rat Brain MitochondriaJournal of Neurochemistry, 1996
- Differences in Nigral Neuron Number and Sensitivity to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 MiceExperimental Neurology, 1994
- Irreversible Inhibition of Mitochondrial Complex I by 1‐Methyl‐4‐Phenylpyridinium: Evidence for Free Radical InvolvementJournal of Neurochemistry, 1992
- 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particlesBiochemical and Biophysical Research Communications, 1990
- Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine and 1‐Methyl‐4‐Phenylpyridinium Ion on Activities of the Enzymes in the Electron Transport System in Mouse BrainJournal of Neurochemistry, 1987
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983